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feasible and relevant for comprehensive hemodynamic assessment
of acute HF.
http://dx.doi.org/10.1016/j.acvd.2013.03.036
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Background.— Mechanical dyssynchrony along with its role in car-
diac resynchronization therapy (CRT) has been studied for over
10 years now. Still, there are no recommendations for the use of
imaging techniques to best select the patients who are the most
likely to positively answer to CRT. We sought, then, to test up-
to-date echocardiographic tools at rest and during a standardized
exercise.
Patients and results.— Thirty out of 197 patients were prospec-
tively recruited. All were chronic heart failure patients in sinus
rhythm, optimally pharmacologically treated but still in NYHA III
and able to perform some degree of exercise. They were fol-
lowed at 6-month. Patients were responders according to a decrease
in left ventricular end-systolic volume> 15%. Responders and non-
responders were signiﬁcantly different at baseline according to
QRS-width (162± 18 vs. 144± 22ms, P = 0.01), left atrial volume
(33± 10 vs. 53± 12mL/m2, P < 0.001), mitral inﬂow duration/RR at
rest and exercise (0.32± 0.05 vs. 0.37± 0.08, P = 0.03), left pre-
ejection time delay (129± 36 vs. 104± 34, P = 0.03) right atrial
area, right ventricular annulus s’ and TAPSE at rest and during
exercise (TAPSE exercise 21.2± 2.9 vs. 16± 6.5, P = 0.004). Using
a stepwise multivariate logistic regression, the exercise mitral
inﬂow duration and the degree of deformation in the LV lateral
wall during exercise were the two best independent predictors of
response.
Conclusion.— Prediction of response to CRT has to be based on
a multivariable analysis including RV function, LA size, but also
dyssynchrony and regional LV function.
http://dx.doi.org/10.1016/j.acvd.2013.03.037
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Prognostic signiﬁcation of left atrial spontaneous
contrast in patients with non valvular atrial
ﬁbrillation and a CHADS2 score=0
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Background.— Transesophageal echocardiography (TEE) can detect
left atrial (LA) thrombus and LA spontaneous echocardiographic
contrast (SEC), which have been associated with a higher risk
of thromboembolism in patients with atrial ﬁbrillation (AF). We
hypothesized that TEE-detected LASEC could predict cardiovascu-
lar events in AF in addition to clinical risk stratiﬁcation in CHADS2
score = 0 patients.
Methods.— Among 763 consecutive patients hospitalized for non
valvular AF (NVAF), prior to cardioversion, TEE was systematically
performed within 24 h after admission; 205 patients had a CHADS2
score = 0. All patients were followed-up (mean 6.3± 4.3 years) and
cardiovascular (CV) events (stroke, death, or heart failure) deﬁning
a composite endpoint were recorded.
Results.— Mean age was 54.5± 13.5 years. NVAF was paroxysmal in
101patients (49.3%), persistent in 82 (40.0%) and permanent in 22
(10.7%). LA thrombus was found in one patient (0.5%), LASEC in
60 (29.3%), classiﬁed as mild in 43 (21.0%), moderate in 14 (6.8%)
and severe in three (1.5%). One hundred seventy six (87.1%) were
prescribed warfarin and 25 (12.4%) aspirin at hospital discharge.
At follow-up, death occurred in 27 patients (13.2%), stroke in ﬁve
(2.4%), heart failure in four (2.0%). AF recurrence was observed
in 60 patients (29.3%) and haemorrhage requiring hospitalization
in ﬁve (2.4%). The Kaplan-Meier (ﬁgure) curves showed that the
presence of LASEC (Yes/No) was associated with a higher risk of CV
events.
Conclusions.— TEE-detected LASEC is associated with a higher risk
of CV events (stroke, death, or heart failure) at long-term follow-up
in NVAF at very low risk of thromboembolism.
http://dx.doi.org/10.1016/j.acvd.2013.03.038
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Is echocardiographic follow-up of importance in
patients presenting with carcinoid tumor and
carcinoid syndrome?
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Background.— Carcinoid heart disease may occur in patients pre-
senting with carcinoid tumor and carcinoid syndrome. Studies
evaluating the echocardiographic follow-up of this speciﬁc popu-
lation remain rare. The aim of this prospective study was to assess
the natural history of cardiac involvement in patients presenting
with carcinoid tumor and carcinoid syndrome.
Methods.— We studied 100 consecutive patients (48 men, 52
women) presenting with carcinoid tumor and carcinoid syndrome.
All patients underwent annual transthoracic echocardiographic
studies and biological carcinoid markers.
Results.— Mean age of our population was 60± 12 years (range 36
to 83). At baseline, prevalence of carcinoid heart disease was 31%,
whereas at the end of follow-up (mean FU: 42months), this preva-
lence was 52% (P = 0.003). Correlations were strong between urinary
5-HIAA and severity score (r = 0.90, P < 0.0001). A carcinoid heart
disease was systematically found in all patients presenting with
at least three years of carcinoid syndrome and increased level
of urinary 5-HIAA. In patients without carcinoid heart disease, no
occurrence of carcinoid heart disease was found after three years
of conventional therapeutic strategy.
Conclusion.— Prevalence of carcinoid heart disease increases during
follow-up. Carcinoid heart disease may progress over time, leading
to perform annual echocardiographic follow-up.
http://dx.doi.org/10.1016/j.acvd.2013.03.039
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LAA closure monitoring by transesophageal
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